M1 Kliniken AG announces that the company’s Supervisory Board has appointed Dr. Walter von Horstig to the Management Board of the company effective October 1,2017. Together with Patrick Brenske, he will drive the further growth and development of the company.
M1 Kliniken AG will publish its interim report in the course of the day. A strong first half-year is the basis for the company’s continuous growth. M1 Kliniken AG has developed very satisfactorily as a result of increasing demand for plastic and aesthetic beauty treatments due to its price and quality leadership.
M1 Kliniken AG announces the acquisition of a building for a surgery center in Essen, Germany. M1 Kliniken AG has acquired a property with 2,000 square meters in the city center of Essen (Germany) and is planning to build a new surgery center there...
M1 Kliniken AG, ISIN: DE000A0STSQ8, announces its preliminary IFRS result for 2016. In 2016 the Frankfurt Stock Exchange listed M1 Kliniken AG again reported a successful fiscal year. The company increased its sales to €36,546,000.